- Home
- BWB vs ESPR Comparison
BWB vs ESPR Comparison
Compare BWB & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWB
- ESPR
- Stock Information
- Founded
- BWB 2005
- ESPR 2008
- Country
- BWB United States
- ESPR United States
- Employees
- BWB N/A
- ESPR N/A
- Industry
- BWB Major Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- BWB Finance
- ESPR Health Care
- Exchange
- BWB Nasdaq
- ESPR Nasdaq
- Market Cap
- BWB 442.3M
- ESPR 445.6M
- IPO Year
- BWB 2018
- ESPR 2013
- Fundamental
- Price
- BWB $16.68
- ESPR $2.84
- Analyst Decision
- BWB Strong Buy
- ESPR Buy
- Analyst Count
- BWB 2
- ESPR 6
- Target Price
- BWB $20.00
- ESPR $6.50
- AVG Volume (30 Days)
- BWB 43.5K
- ESPR 6.1M
- Earning Date
- BWB 10-22-2025
- ESPR 11-06-2025
- Dividend Yield
- BWB N/A
- ESPR N/A
- EPS Growth
- BWB 12.01
- ESPR N/A
- EPS
- BWB 1.21
- ESPR N/A
- Revenue
- BWB $119,312,000.00
- ESPR $268,125,000.00
- Revenue This Year
- BWB $35.51
- ESPR $10.59
- Revenue Next Year
- BWB $11.83
- ESPR N/A
- P/E Ratio
- BWB $13.69
- ESPR N/A
- Revenue Growth
- BWB 12.23
- ESPR N/A
- 52 Week Low
- BWB $11.93
- ESPR $0.69
- 52 Week High
- BWB $17.66
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- BWB 59.02
- ESPR 79.27
- Support Level
- BWB $16.30
- ESPR $2.37
- Resistance Level
- BWB $16.69
- ESPR $2.73
- Average True Range (ATR)
- BWB 0.35
- ESPR 0.17
- MACD
- BWB 0.03
- ESPR 0.03
- Stochastic Oscillator
- BWB 98.72
- ESPR 93.75
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.